← Back to headlines
ImmunityBio Soars After EU Approves ANKTIVA for Bladder Cancer
ImmunityBio's stock surged following the EU's approval of ANKTIVA for bladder cancer treatment.
18 Feb, 22:37 — 18 Feb, 22:37
ImmunityBio's stock surged following the EU's approval of ANKTIVA for bladder cancer treatment.
18 Feb, 22:37 — 18 Feb, 22:37
